Low expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer

Abstract Advanced gastric cancer (GC) is one of the most lethal cancer types, thus a better understanding of its biology in patients is urgently needed. MicroRNA (miR)-29a is a known tumor suppressive miR that is related to metastasis, but its clinical relevance in GC remains ambiguous. Here, using...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yoshihisa Tokumaru, Masanori Oshi, Michelle R. Huyser, Li Yan, Masahiro Fukada, Nobuhisa Matsuhashi, Manabu Futamura, Yukihiro Akao, Kazuhiro Yoshida, Kazuaki Takabe
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/2e78e900ae834d0e990a3b64daadad1c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2e78e900ae834d0e990a3b64daadad1c
record_format dspace
spelling oai:doaj.org-article:2e78e900ae834d0e990a3b64daadad1c2021-12-02T15:40:00ZLow expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer10.1038/s41598-021-93681-z2045-2322https://doaj.org/article/2e78e900ae834d0e990a3b64daadad1c2021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-93681-zhttps://doaj.org/toc/2045-2322Abstract Advanced gastric cancer (GC) is one of the most lethal cancer types, thus a better understanding of its biology in patients is urgently needed. MicroRNA (miR)-29a is a known tumor suppressive miR that is related to metastasis, but its clinical relevance in GC remains ambiguous. Here, using a large GC patient cohort we hypothesized that low expression of miR-29a in GC is associated with aggressive cancer biology and worse survival. We demonstrated that low miR-29a GC enriched cell proliferation, apoptosis, metastasis, and angiogenesis related gene sets, as well as the higher expression of related genes. Low miR-29a GC was associated with less anti-cancer immune cell infiltration as well as immune related scoring. Low miR-29a GC demonstrated a worse overall survival (OS) as well as disease specific survival (DSS) compared with high expressing miR-29a GC. Notably, low miR-29a expression was the only factor, other than residual tumor status, to be an independent prognostic biomarker of worse OS and DSS. In conclusion, low miR-29a GC was associated with aggressive cancer biology and worse OS as well as DSS. Additionally, low expression of miR-29a was an independent prognostic biomarker of OS and DSS in gastric cancer patients.Yoshihisa TokumaruMasanori OshiMichelle R. HuyserLi YanMasahiro FukadaNobuhisa MatsuhashiManabu FutamuraYukihiro AkaoKazuhiro YoshidaKazuaki TakabeNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yoshihisa Tokumaru
Masanori Oshi
Michelle R. Huyser
Li Yan
Masahiro Fukada
Nobuhisa Matsuhashi
Manabu Futamura
Yukihiro Akao
Kazuhiro Yoshida
Kazuaki Takabe
Low expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer
description Abstract Advanced gastric cancer (GC) is one of the most lethal cancer types, thus a better understanding of its biology in patients is urgently needed. MicroRNA (miR)-29a is a known tumor suppressive miR that is related to metastasis, but its clinical relevance in GC remains ambiguous. Here, using a large GC patient cohort we hypothesized that low expression of miR-29a in GC is associated with aggressive cancer biology and worse survival. We demonstrated that low miR-29a GC enriched cell proliferation, apoptosis, metastasis, and angiogenesis related gene sets, as well as the higher expression of related genes. Low miR-29a GC was associated with less anti-cancer immune cell infiltration as well as immune related scoring. Low miR-29a GC demonstrated a worse overall survival (OS) as well as disease specific survival (DSS) compared with high expressing miR-29a GC. Notably, low miR-29a expression was the only factor, other than residual tumor status, to be an independent prognostic biomarker of worse OS and DSS. In conclusion, low miR-29a GC was associated with aggressive cancer biology and worse OS as well as DSS. Additionally, low expression of miR-29a was an independent prognostic biomarker of OS and DSS in gastric cancer patients.
format article
author Yoshihisa Tokumaru
Masanori Oshi
Michelle R. Huyser
Li Yan
Masahiro Fukada
Nobuhisa Matsuhashi
Manabu Futamura
Yukihiro Akao
Kazuhiro Yoshida
Kazuaki Takabe
author_facet Yoshihisa Tokumaru
Masanori Oshi
Michelle R. Huyser
Li Yan
Masahiro Fukada
Nobuhisa Matsuhashi
Manabu Futamura
Yukihiro Akao
Kazuhiro Yoshida
Kazuaki Takabe
author_sort Yoshihisa Tokumaru
title Low expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer
title_short Low expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer
title_full Low expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer
title_fullStr Low expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer
title_full_unstemmed Low expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer
title_sort low expression of mir-29a is associated with aggressive biology and worse survival in gastric cancer
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/2e78e900ae834d0e990a3b64daadad1c
work_keys_str_mv AT yoshihisatokumaru lowexpressionofmir29aisassociatedwithaggressivebiologyandworsesurvivalingastriccancer
AT masanorioshi lowexpressionofmir29aisassociatedwithaggressivebiologyandworsesurvivalingastriccancer
AT michellerhuyser lowexpressionofmir29aisassociatedwithaggressivebiologyandworsesurvivalingastriccancer
AT liyan lowexpressionofmir29aisassociatedwithaggressivebiologyandworsesurvivalingastriccancer
AT masahirofukada lowexpressionofmir29aisassociatedwithaggressivebiologyandworsesurvivalingastriccancer
AT nobuhisamatsuhashi lowexpressionofmir29aisassociatedwithaggressivebiologyandworsesurvivalingastriccancer
AT manabufutamura lowexpressionofmir29aisassociatedwithaggressivebiologyandworsesurvivalingastriccancer
AT yukihiroakao lowexpressionofmir29aisassociatedwithaggressivebiologyandworsesurvivalingastriccancer
AT kazuhiroyoshida lowexpressionofmir29aisassociatedwithaggressivebiologyandworsesurvivalingastriccancer
AT kazuakitakabe lowexpressionofmir29aisassociatedwithaggressivebiologyandworsesurvivalingastriccancer
_version_ 1718385862871351296